Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aditya Kotha

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Personalized Medicine|March 27, 2026
Precision Medicine in Inflammatory Bowel Disease: The Emerging Role of Metabolic DysfunctionAditya Kotha, Arun J Sanyal, Raseen Tariq
Cells|October 14, 2022
Targeting Mast Cells in Allergic Disease: Current Therapies and Drug RepurposingJason R Burchett, Jordan M Dailey, Sydney A Kee, et al.
Clinical Reviews in Allergy & Immunology|April 10, 2026
Sexual Dimorphism in Allergic and Mast Cell-Associated DiseasesAditya Kotha, Tania D Maldonado, Hadi Hamze, et al.
Frontiers in Immunology|December 29, 2025
IL-33-mediated mast cell and eosinophil function requires isoprenylationJason R Burchett, Aditya Kotha, Destiny T Davis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2024
IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell FunctionMarcela T Taruselli, Amina Abdul Qayum, Daniel Abebayehu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2023
Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic InflammationJordan M Dailey, Sydney A Kee, Anuj Tharakan, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Personalized Medicine|March 27, 2026
Precision Medicine in Inflammatory Bowel Disease: The Emerging Role of Metabolic DysfunctionAditya Kotha, Arun J Sanyal, Raseen Tariq
Cells|October 14, 2022
Targeting Mast Cells in Allergic Disease: Current Therapies and Drug RepurposingJason R Burchett, Jordan M Dailey, Sydney A Kee, et al.
Clinical Reviews in Allergy & Immunology|April 10, 2026
Sexual Dimorphism in Allergic and Mast Cell-Associated DiseasesAditya Kotha, Tania D Maldonado, Hadi Hamze, et al.
Frontiers in Immunology|December 29, 2025
IL-33-mediated mast cell and eosinophil function requires isoprenylationJason R Burchett, Aditya Kotha, Destiny T Davis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2024
IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell FunctionMarcela T Taruselli, Amina Abdul Qayum, Daniel Abebayehu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2023
Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic InflammationJordan M Dailey, Sydney A Kee, Anuj Tharakan, et al.
Pageof 1